HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese.

Abstract
To investigate the association between HLA antigens and Graves' disease among Japanese, serologic typing and DPB1 genotyping using the PCR-RFLP method have been performed. HLA alleles of 106 patients with Graves' disease were determined, and the frequency of HLA-B46 was found to be significantly increased. Furthermore, the frequencies of HLA antigens were compared between two age groups: early-onset and late-onset patients (under and over 20 years, respectively). It was found that the frequency of DPB1*0501 (88.9%) was significantly increased (pc < 0.004) in the early-onset group as compared with the healthy controls (55.0%) but not in the late-onset group (60.7%). On the other hand, a significant increase of HLA-B46 was observed in the late-onset patients (pc < 0.0004). These results suggest that the genetic background of Japanese patients with early-onset Graves' disease is different from late-onset patients. Namely, the HLA-DP allele (DPB1*0501) and the HLA-B allele (B46) are primarily involved in the pathogenesis of early-onset and late-onset Graves' disease in Japanese, respectively.
AuthorsH Onuma, M Ota, A Sugenoya, H Inoko
JournalHuman immunology (Hum Immunol) Vol. 39 Issue 3 Pg. 195-201 (Mar 1994) ISSN: 0198-8859 [Print] United States
PMID8026987 (Publication Type: Journal Article)
Chemical References
  • HLA Antigens
  • HLA-DP Antigens
  • HLA-DP beta-Chains
  • HLA-DPB1 antigen
  • Triiodothyronine
  • Thyroxine
Topics
  • Adolescent
  • Adult
  • Disease Susceptibility (immunology)
  • Female
  • Genetic Predisposition to Disease
  • Graves Disease (genetics, immunology)
  • HLA Antigens (genetics)
  • HLA-DP Antigens (genetics)
  • HLA-DP beta-Chains
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Thyroxine (blood)
  • Triiodothyronine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: